
### [NCIT:C4839](http://purl.obolibrary.org/obo/NCIT_C4839)
**Label:** Esophageal Intraepithelial Neoplasia

**Subclasses:** [NCIT:C8629](http://purl.obolibrary.org/obo/NCIT_C8629) (Stage 0 Esophageal Adenocarcinoma AJCC v7), [NCIT:C27423](http://purl.obolibrary.org/obo/NCIT_C27423) (Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C4840](http://purl.obolibrary.org/obo/NCIT_C4840) (Esophageal Low Grade Intraepithelial Neoplasia), [NCIT:C27429](http://purl.obolibrary.org/obo/NCIT_C27429) (High Grade Esophageal Glandular Intraepithelial Neoplasia), [NCIT:C5023](http://purl.obolibrary.org/obo/NCIT_C5023) (Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C27428](http://purl.obolibrary.org/obo/NCIT_C27428) (Low Grade Esophageal Glandular Intraepithelial Neoplasia), [NCIT:C27425](http://purl.obolibrary.org/obo/NCIT_C27425) (Esophageal High Grade Intraepithelial Neoplasia), [NCIT:C27424](http://purl.obolibrary.org/obo/NCIT_C27424) (Esophageal Glandular Intraepithelial Neoplasia), [NCIT:C27427](http://purl.obolibrary.org/obo/NCIT_C27427) (Low Grade Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C27426](http://purl.obolibrary.org/obo/NCIT_C27426) (High Grade Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C95613](http://purl.obolibrary.org/obo/NCIT_C95613) (Intraepithelial Neoplasia in Barrett Esophagus), [NCIT:C3637](http://purl.obolibrary.org/obo/NCIT_C3637) (Stage 0 Esophageal Cancer AJCC v6), [NCIT:C89771](http://purl.obolibrary.org/obo/NCIT_C89771) (Stage 0 Esophageal Cancer AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C118376](http://purl.obolibrary.org/obo/NCIT_C118376) (FGF Gene Amplification) 57.69%
- [NCIT:C118376](http://purl.obolibrary.org/obo/NCIT_C118376) (FGF Gene Amplification) and [NCIT:C36344](http://purl.obolibrary.org/obo/NCIT_C36344) (Oncogene Deregulation) 57.69%
- [NCIT:C36327](http://purl.obolibrary.org/obo/NCIT_C36327) (Gene Abnormality) 55.99%
- [NCIT:C36391](http://purl.obolibrary.org/obo/NCIT_C36391) (Molecular Genetic Variation) 54.37%
- [NCIT:C97926](http://purl.obolibrary.org/obo/NCIT_C97926) (Molecular Sequence Variation) 54.03%
- [UBERON:0006920](http://purl.obolibrary.org/obo/UBERON_0006920) (esophagus squamous epithelium) 53.85%
- [NCIT:C41380](http://purl.obolibrary.org/obo/NCIT_C41380) (FGF6 Gene Amplification) 53.85%
- [NCIT:C41379](http://purl.obolibrary.org/obo/NCIT_C41379) (FGF4 Gene Amplification) 53.85%
- [NCIT:C39629](http://purl.obolibrary.org/obo/NCIT_C39629) (CDKN2A Gene Inactivation) 53.85%
- [NCIT:C36704](http://purl.obolibrary.org/obo/NCIT_C36704) (FHIT Gene Inactivation) 53.85%
- [NCIT:C36683](http://purl.obolibrary.org/obo/NCIT_C36683) (APC Gene Inactivation) 53.85%
- [NCIT:C36652](http://purl.obolibrary.org/obo/NCIT_C36652) (CCND1 Gene Amplification) 53.85%
- [NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification) 53.85%
- [NCIT:C36644](http://purl.obolibrary.org/obo/NCIT_C36644) (Loss of E-cadherin Expression) 53.85%
- [NCIT:C36641](http://purl.obolibrary.org/obo/NCIT_C36641) (MYC Gene Amplification) 53.85%


